Please don't hesitate to contact us if you have any questions or other inquiries.

American Heart Association Scientific Sessions 2022

Nordic Bioscience is excited to participate in the Scientific Sessions provided by the American Heart Association in 2022. Our team of scientists is ready to take a deep dive into the field of cardiovascular diseases.

Recently, Nordic Bioscience, together with BMS and Upenn, have published in NEJM Evidence about the clinical utility of the PRO-C6 biomarker in heart failure with preserved ejection fraction. PRO-C6, measuring the signaling molecule endotrophin, is a robust cardiac biomarker in heart failure that received a letter of support from the FDA.

"Programming that covers basic, clinical, and population science presented by global thought leaders. Customize your educational journey from a variety of session types:

  • Featured – Presented on the Main Event stages and live-streamed on the virtual platform, including Late-Breaking and Featured Science selections.
  • Multi-Disciplinary – Sessions for sub-specialties and interests. Includes posters and oral abstracts
  • Health Equity – Programming focused on strategies to promote the delivery of equitable healthcare.
  • International Rebroadcast – Rebroadcasting three of the top Late-Breaking Science sessions at the times convenient for Pacific Rim-region colleagues to attend in their own time zone. Topics are focused on improving health by championing scientific discovery and practice-changing content." (American Heart Association)


If you have any questions about our research in heart failure or would like to know more about our biomarkers in cardiovascular disease, don't hesitate to reach out to us.


Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.